|
gptkbp:instance_of
|
gptkb:immunotherapy
|
|
gptkbp:administered_by
|
supportive care
intravenous route
oral route
|
|
gptkbp:associated_with
|
reduced malaria transmission
|
|
gptkbp:can_be_combined_with
|
gptkb:lumefantrine
gptkb:mefloquine
gptkb:piperaquine
non-artemisinin drugs
|
|
gptkbp:developed_by
|
gptkb:artemisinin
gptkb:China
gptkb:sweet_wormwood
gptkb:scientists
|
|
gptkbp:first_introduced
|
1970s
|
|
gptkbp:has_cultural_impact
|
malaria control
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
artemisinin-based therapies
|
|
gptkbp:improves_survival_rate_in
|
severe malaria
|
|
gptkbp:includes
|
gptkb:artemether
gptkb:artesunate
gptkb:dihydroartemisinin
|
|
gptkbp:influenced_by
|
climate change
|
|
gptkbp:is_associated_with
|
improved patient compliance
|
|
gptkbp:is_challenged_by
|
drug resistance
|
|
gptkbp:is_considered_as
|
first-line treatment
|
|
gptkbp:is_effective_against
|
gptkb:children
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_vivax
adults
|
|
gptkbp:is_evaluated_by
|
field studies
clinical research
cost-effectiveness
|
|
gptkbp:is_funded_by
|
government agencies
|
|
gptkbp:is_informed_by
|
epidemiological studies
|
|
gptkbp:is_linked_to
|
improved health outcomes
reduced mortality rates
reduction in malaria cases
|
|
gptkbp:is_monitored_by
|
drug resistance
|
|
gptkbp:is_part_of
|
global health initiatives
treatment protocols
treatment regimens
malaria treatment guidelines
|
|
gptkbp:is_promoted_by
|
healthcare providers
international health organizations
|
|
gptkbp:is_promoted_through
|
public health campaigns
|
|
gptkbp:is_recommended_by
|
gptkb:World_Health_Organization
|
|
gptkbp:is_recommended_for
|
uncomplicated malaria
|
|
gptkbp:is_studied_for
|
efficacy
safety profile
|
|
gptkbp:is_subject_to
|
gptkb:guidelines
regulatory approval
|
|
gptkbp:is_supported_by
|
non-profit organizations
clinical trials
|
|
gptkbp:is_used_for
|
malaria prevention
|
|
gptkbp:is_used_in
|
tropical regions
endemic regions
|
|
gptkbp:part_of
|
combination therapy
|
|
gptkbp:reduces_parasite_load_in
|
malaria patients
|
|
gptkbp:requires
|
proper dosing
diagnosis of malaria
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
vomiting
|
|
gptkbp:suitable_for
|
severe liver disease patients
pregnant women in first trimester
|
|
gptkbp:used_for
|
treating malaria
|
|
gptkbp:bfsParent
|
gptkb:Tu_Youyou
|
|
gptkbp:bfsLayer
|
6
|